文献速递生殖医学

非整倍体胚胎移植:美国生育诊所的临床政策与提供者意见

Aneuploid embryo transfer: clinical policies and provider opinions at United States fertility clinics.
PubMed 文献 · Fertil Steril · 2020-01-01

该研究通过电子调查向SART成员实验室主任和全体成员分别发送临床政策问卷和个人意见问卷,共48名实验室主任和212名提供者回复。结果显示25%的诊所无aET政策,半数提供者同意21三体胚胎可移植,但多数反对其他非整倍体移植,对嵌合体胚胎多数不确定或不情愿。结论认为aET临床政策缺乏共识,实践与意见差异大,亟需专业指南。

要点

  • 12家(25%)诊所报告无aET政策,年PGT-A周期>100的诊所更可能制定政策。
  • 半数提供者同意21三体胚胎可移植,但多数反对其他非整倍体移植。
  • 多数提供者对嵌合体胚胎移植不确定或不情愿,面对面角色者意见更积极。

核心结论

  • 关于aET的理想临床政策尚无共识,当前临床实践和提供者个人意见差异广泛,表明这是ART提供者中存在分歧的问题,明确需要专业指南来规范。

研究设计与样本

  • 通过电子调查向SART成员实验室主任发送临床政策问卷,并向所有SART成员发送个人意见问卷,分别收集aET相关政策和意见。
  • 共48名实验室主任和212名个体提供者回复各自问卷。

主要发现

  • 12家(25%)诊所报告没有关于aET的政策。
  • 年PGT-A周期>100的诊所更可能制定aET政策。
  • 半数个体提供者同意21三体胚胎可进行aET。
  • 多数提供者反对其他非整倍体胚胎的aET。
  • 多数提供者对嵌合体胚胎移植不确定或不情愿。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe institutional clinical policies and individual provider opinions regarding aneuploid embryo transfer (aET). DESIGN: A survey about clinical policies was electronically sent to Society for Assisted Reproductive Technology (SART) member laboratory directors, and a separate survey about personal opinions was electronically sent to all SART members. SETTING: Not applicable. PATIENTS: Patients pursuing preimplantation genetic testing for aneuploidy (PGT-A). INTERVENTION: Not applicable. MAIN OUTCOME MEASURES: Current clinical policies about aET were described. Individual provider opinions about aET in the context of specific aneuploidies and mosaicism were also described. RESULTS: A total of 48 laboratory directors and 212 individual providers responded to their respective surveys. Twelve (25%) clinics report that they do not have a policy regarding aET, but clinics performing PGT-A in >100 cycles per year were more likely to have a policy. Half of the individual providers agree that an embryo with trisomy 21 should be available for aET, but most disagreed with aET of embryos with other aneuploidies and most were either unsure about or unwilling to transfer embryos with mosaicism. Those who worked in primarily patient-facing roles held more agreeable opinions regarding aET. CONCLUSION: There is no consensus regarding ideal clinical policies for aET. The wide range of current clinical practices and individual provider opinions regarding under what circumstances, if any, aET should be available to patients indicates that this is a divisive issue among ART providers, and there is a clear need for specific professional guidelines to address this issue.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. McGowan R, Pilipenko V, Smolarek TA, et al. Aneuploid embryo transfer: clinical policies and provider opinions at United States fertility clinics. Fertil Steril. 2020. PMID: 32622405. doi:10.1016/j.fertnstert.2020.03.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。